Table of Contents Table of Contents
Previous Page  313 / 354 Next Page
Information
Show Menu
Previous Page 313 / 354 Next Page
Page Background

274

National Health Profile 2018

6.3 (Contd.) Vaccinewise and Institution-wise status of production, demand and

supply 2015-16 & 2016-17.

10. Typhoid (Vi-Poly) - Installed Capcity, Production, Demand and Supply

Quantity in Lakh of Doses

S.

No

Institutions

Installed

Capacity

2015-16

2016-17

Status as on

Prodtn.

Demand supply % Achieved

Prodtn.

Demand supply % Achieved

1 Bio-Med (P) Ltd. Ghaziabad

120

14.8

13.7

13.7

100.00

14.8

13.7

13.7

100.00 March,2016

2 Zydus Aventis Ahmedabad

30

0

9

0

0.00

0

9

0

0.00 March,2014

3 BBI (L). Hy'bad

300

21

19.15

19.15

100.00

21

19.15

19.15

100.00 March,2014

4 Bharat Biotech Int.Ltd*

250

10

4.5

4.57

101.56

10

4.5

4.57

101.56 March, 2015

5 SanofiPasteurDelhi

4.06

4.54

4.54

100.00

4.06

4.54

4.54

100.00 March,2014

6 Bharat Biotech, Hy'd*

250

10

4.57

4.57

100.00

10

4.57

4.57

100.00 March,2015

Total

950

59.86

55.46

46.53

83.90

59.86

55.46

46.53

83.90

*

Newly added Institutions.

11. Typhoid (AKD) - Installed Capcity, Production, Demand and Supply

S.

No

Institutions

Installed

Capacity

2015-16

2016-17

Status as on

Prodtn.

Demand supply % Achieved

Prodtn.

Demand supply % Achieved

1 Bharat Biotecch Int.* Ltd

800

40

21.77

21.77

100.00

40

21.77

21.77

100.00 March,2015

2 Bio-Med Pvt. Ltd., Ghaziabad*

120

10.2

10.2

10.2

100.00

11.45

6.51

6.51

100.00 March,2017

Total

920

50.2

31.97

31.97

100.00

51.45

28.28

28.28

100.00

*

New Institution.

12. Hepatitis-B - Installed Capcity, Production, Demand and Supply*

S.

No

Institutions

Installed

Capacity

2015-16

2016-17

Status as on

Prodtn.

Demand supply % Achieved

Prodtn.

Demand supply % Achieved

1 SII Pune

2700

502

-

-

NA

806

NA

NA

NA March,2017

2 Panacea Bio-tech ltd. New Delhi-

multidose presentation

1670

-

-

-

NA

-

-

-

- March, 2013

2a Panacea Bio-tech Ltd. New Delhi-

single dose presentation

350

0

0

0

NA

0

0

0

- March, 2010

3 BBI (L), Hy'bad,

1000

2100

564.8

564.8

100.00

2100

564.8

564.8

100.00 March, 2011

4 HBI Udhagamandalam Hyderabad

400

164.3

-

157.8

NA

164.3

-

157.8

- March, 2016

5 Shanta bio technic Pvt. Ltd. Hy,bad

1200

213

588

546

92.86

213

588

546

92.86 March, 2013

6 Biological-E-Ltd.

1000

237.3

237.3

237.3

100.00

70

47.05

47.05

100.00 March, 2017

7 Bharat Biotech Int. Ltd*

1010

105

65.14

65.14

100.00

105

65.14

65.14

100.00 March, 2015

8 Sanofi Pasture India

8.3

8.58

8.58

100.00

8.3

8.58

8.58

100.00 March, 2013

Total

9330

3329.9 1463.82 1579.62

107.91

3466.6 1273.57 1389.37

109.09

*

New Institution.

13. Quaderivalent Meningococcal Minigitis Vaccine (QMMV) - Installed Capacity, Production, Demand and Supply

S.

No

Institutions

Installed

Capacity

2015-16

2016-17

Status as on

Prodtn.

Demand supply % Achieved

Prodtn.

Demand supply % Achieved

1 Bio-Med (P) Ltd. Ghaziabad

0.2

11.7

6.7

6.7

100.00

7.06

7.23

7.23

100.00 March, 2017

2 Sanofi Pasture India

NA

2.1

1.38

1.38

100.00

2.1

1.38

1.38

100.00 March, 2011

Total

0.2

13.8

8.08

8.08

100.00

9.16

8.61

8.61

100.00

14. Haemophilis (Hib) Influenzae vaccine - Installed Capacity, Production Demand and Supply

S.

No

Institutions

Installed

Capacity

2015-16

2016-17

Status as on

Prodtn.

Demand supply % Achieved

Prodtn.

Demand supply % Achieved

1 Bio-Med (P) Ltd. Ghaziabad

20

0.4

0.5

0.5

100.00

0.4

0.5

0.5

100.00 March, 2017

2 Biological E Ltd.Hyderabad

10

3.08

3.06

3.06

100.00

2

0.3

0.3

100.00 March,2017

3 Panacae

67.5

Nil

1.34

0.5

37.31

Nil

0.16

0.16

100.00 March,2017

4 Shanta Biotech. Ltd. H'bad

1000

-

-

-

-

-

-

-

- March, 2010

5 Sill Pune

1000

36

-

-

-

46

NA

NA

NA March,2017

6 Bharat Biotech

200

4

0.71

0.71

100.00

4

0.71

0.71

100.00 March, 2015

Total

2297.5

43.48

5.61

4.77

85.03

52.4

1.67

1.67

100.00